84 related articles for article (PubMed ID: 34032336)
21. The emerging role of deubiquitylating enzymes as therapeutic targets in cancer metabolism.
Tu R; Ma J; Zhang P; Kang Y; Xiong X; Zhu J; Li M; Zhang C
Cancer Cell Int; 2022 Mar; 22(1):130. PubMed ID: 35307036
[TBL] [Abstract][Full Text] [Related]
22. Novel roles of reactive oxygen species in the pathogenesis of acute myeloid leukemia.
Zhou F; Shen Q; Claret FX
J Leukoc Biol; 2013 Sep; 94(3):423-9. PubMed ID: 23715741
[TBL] [Abstract][Full Text] [Related]
23. VLX1570 induces apoptosis through the generation of ROS and induction of ER stress on leukemia cell lines.
Kurozumi N; Tsujioka T; Ouchida M; Sakakibara K; Nakahara T; Suemori SI; Takeuchi M; Kitanaka A; Shibakura M; Tohyama K
Cancer Sci; 2021 Aug; 112(8):3302-3313. PubMed ID: 34032336
[TBL] [Abstract][Full Text] [Related]
24. Sensitivity of Acute Myelocytic Leukemia Cells to the Dienone Compound VLX1570 Is Associated with Inhibition of the Ubiquitin-Proteasome System.
Selvaraju K; Lotfi K; Gubat J; Miquel M; Nilsson A; Hill J; Jensen LD; Linder S; D'Arcy P
Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572552
[TBL] [Abstract][Full Text] [Related]
25. Acute lymphoblastic leukemia cells are sensitive to disturbances in protein homeostasis induced by proteasome deubiquitinase inhibition.
Mazurkiewicz M; Hillert EK; Wang X; Pellegrini P; Olofsson MH; Selvaraju K; D'Arcy P; Linder S
Oncotarget; 2017 Mar; 8(13):21115-21127. PubMed ID: 28423502
[TBL] [Abstract][Full Text] [Related]
26. The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells.
Wang X; Mazurkiewicz M; Hillert EK; Olofsson MH; Pierrou S; Hillertz P; Gullbo J; Selvaraju K; Paulus A; Akhtar S; Bossler F; Khan AC; Linder S; D'Arcy P
Sci Rep; 2016 Jun; 6():26979. PubMed ID: 27264969
[TBL] [Abstract][Full Text] [Related]
27. Fucoidan induces Toll-like receptor 4-regulated reactive oxygen species and promotes endoplasmic reticulum stress-mediated apoptosis in lung cancer.
Hsu HY; Lin TY; Lu MK; Leng PJ; Tsao SM; Wu YC
Sci Rep; 2017 Mar; 7():44990. PubMed ID: 28332554
[TBL] [Abstract][Full Text] [Related]
28. Dienone Compounds: Targets and Pharmacological Responses.
Bazzaro M; Linder S
J Med Chem; 2020 Dec; 63(24):15075-15093. PubMed ID: 33146523
[TBL] [Abstract][Full Text] [Related]
29. Effect of crocin and naringenin supplementation in cryopreservation medium on post-thaw rooster sperm quality and expression of apoptosis associated genes.
Mehdipour M; Daghigh Kia H; Najafi A; Mohammadi H; Álvarez-Rodriguez M
PLoS One; 2020; 15(10):e0241105. PubMed ID: 33119667
[TBL] [Abstract][Full Text] [Related]
30. Induction of ER Stress in Acute Lymphoblastic Leukemia Cells by the Deubiquitinase Inhibitor VLX1570.
Pellegrini P; Selvaraju K; Faustini E; Mofers A; Zhang X; Ternerot J; Schubert A; Linder S; D Arcy P
Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32635430
[TBL] [Abstract][Full Text] [Related]
31. Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma.
Rowinsky EK; Paner A; Berdeja JG; Paba-Prada C; Venugopal P; Porkka K; Gullbo J; Linder S; Loskog A; Richardson PG; Landgren O
Invest New Drugs; 2020 Oct; 38(5):1448-1453. PubMed ID: 32125598
[TBL] [Abstract][Full Text] [Related]
32. Re-Evaluating the Mechanism of Action of α,β-Unsaturated Carbonyl DUB Inhibitors b-AP15 and VLX1570: A Paradigmatic Example of Unspecific Protein Cross-linking with Michael Acceptor Motif-Containing Drugs.
Ward JA; Pinto-Fernandez A; Cornelissen L; Bonham S; Díaz-Sáez L; Riant O; Huber KVM; Kessler BM; Feron O; Tate EW
J Med Chem; 2020 Apr; 63(7):3756-3762. PubMed ID: 32109059
[TBL] [Abstract][Full Text] [Related]
33. Analysis of determinants for in vitro resistance to the small molecule deubiquitinase inhibitor b-AP15.
Mofers A; Perego P; Selvaraju K; Gatti L; Gullbo J; Linder S; D'Arcy P
PLoS One; 2019; 14(10):e0223807. PubMed ID: 31639138
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
